Collplant Biotechnologies Ltd (CLGN) — Cash Flow-to-Debt Ratio
Collplant Biotechnologies Ltd (CLGN) has a Cash Flow-to-Debt Ratio of -0.60x as of September 2025, meaning its operating cash flow of $-2.88 Million could theoretically repay -1% of its total liabilities ($4.78 Million) in one year. See CLGN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Collplant Biotechnologies Ltd Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Collplant Biotechnologies Ltd across 13 annual periods. Also explore Collplant Biotechnologies Ltd (CLGN) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Collplant Biotechnologies Ltd (2012–2024)
Year-by-year debt coverage analysis for Collplant Biotechnologies Ltd. For market capitalisation and broader financial context, see CLGN market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.69x | $-14.09 Million | $5.25 Million | ▼ -462.7% |
| 2023 | -0.48x | $-2.76 Million | $5.79 Million | ▲ +80.9% |
| 2022 | -2.50x | $-13.70 Million | $5.49 Million | ▼ -709.2% |
| 2021 | 0.41x | $2.50 Million | $6.10 Million | ▲ +158.6% |
| 2020 | -0.70x | $-4.45 Million | $6.36 Million | ▲ +18.3% |
| 2019 | -0.86x | $-5.70 Million | $6.66 Million | ▼ -201.7% |
| 2018 | -0.28x | $-1.22 Million | $4.29 Million | ▲ +68.8% |
| 2017 | -0.91x | $-4.97 Million | $5.46 Million | ▲ +56.3% |
| 2016 | -2.08x | $-5.02 Million | $2.41 Million | ▲ +46.2% |
| 2015 | -3.87x | $-3.72 Million | $960.64K | ▲ +20.8% |
| 2014 | -4.89x | $-3.33 Million | $679.77K | ▼ -17.3% |
| 2013 | -4.17x | $-3.82 Million | $915.72K | ▲ +13.9% |
| 2012 | -4.84x | $-3.86 Million | $797.87K | — |